Pet Cancer Therapeutics Market
Pet Cancer Therapeutics Market - Global Industry Assessment & Forecast
#
Pages:
190
Base Year:
2023
Jul - 2024
Format:
Report Code:
VMR-2541
Segments Covered
By
Therapy Chemotherapy, Immunotherapy, Targeted Therapy, Combination Therapy
-
By
Route of Administration Oral, Injection
-
By
Species Dogs, Cats
-
By
Application Lymphoma, Mast Cell Cancer, Melanoma, Mammary and Squamous Cell Cancer, Other Applications
-
By
Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
 Base Year:
|
2023 |
| Forecast
Years:
|
2024 - 2032 |
 Historical
Years:
|
2018 - 2022 |
 Revenue
2023: |
USD 411 Million |
 Revenue 2032:
|
USD 971 Million |
 Revenue CAGR
(2024 - 2032): |
10.1% |
Fastest Growing Region (2024 -
2032)
|
Asia Pacific |
Largest Region (2023):
|
North America |
Customization Offered
Cross-segment Market Size and
Analysis
for Mentioned Segments- Additional Company Profiles (Upto 5
With
No Cost)
- Additional Countries (Apart From
Mentioned Countries)
- Country/Region-specific Report
- Go To Market Strategy
- Region Specific Market Dynamics
- Region Level Market Share
- Import Export Analysis
- Production Analysis
- Others Request
Customization Speak To
Analyst
Pet Cancer Therapeutics Market Segment Analysis
- Pet Cancer Therapeutics Therapy Outlook (Revenue, USD Million, 2018 - 2030)
- Chemotherapy
- Immunotherapy
- Targeted Therapy
- Combination Therapy
- Pet Cancer Therapeutics Route of Administration Outlook (Revenue, USD Million, 2018 - 2030)
- Oral
- Injection
- Pet Cancer Therapeutics Species Outlook (Revenue, USD Million, 2018 - 2030)
- Dogs
- Cats
- Pet Cancer Therapeutics Application Outlook (Revenue, USD Million, 2018 - 2030)
- Lymphoma
- Mast Cell Cancer
- Melanoma
- Mammary and Squamous Cell Cancer
- Other Applications
-
Regional Outlook (Revenue, USD Billion/Million, 2018 - 2030)
- North America
-
North America Pet Cancer Therapeutics Market, by Therapy
- Chemotherapy
- Immunotherapy
- Targeted Therapy
- Combination Therapy
-
North America Pet Cancer Therapeutics Market, by Route of Administration
- Oral
- Injection
-
North America Pet Cancer Therapeutics Market, by Species
- Dogs
- Cats
-
North America Pet Cancer Therapeutics Market, by Application
- Lymphoma
- Mast Cell Cancer
- Melanoma
- Mammary and Squamous Cell Cancer
- Other Applications
- U.S.
- U.S. Pet Cancer Therapeutics Market, by Therapy
- Chemotherapy
- Immunotherapy
- Targeted Therapy
- Combination Therapy
- U.S. Pet Cancer Therapeutics Market, by Route of Administration
- Oral
- Injection
- U.S. Pet Cancer Therapeutics Market, by Species
- Dogs
- Cats
- U.S. Pet Cancer Therapeutics Market, by Application
- Lymphoma
- Mast Cell Cancer
- Melanoma
- Mammary and Squamous Cell Cancer
- Other Applications
- U.S. Pet Cancer Therapeutics Market, by Therapy
- Canada
- Canada Pet Cancer Therapeutics Market, by Therapy
- Chemotherapy
- Immunotherapy
- Targeted Therapy
- Combination Therapy
- Canada Pet Cancer Therapeutics Market, by Route of Administration
- Oral
- Injection
- Canada Pet Cancer Therapeutics Market, by Species
- Dogs
- Cats
- Canada Pet Cancer Therapeutics Market, by Application
- Lymphoma
- Mast Cell Cancer
- Melanoma
- Mammary and Squamous Cell Cancer
- Other Applications
- Canada Pet Cancer Therapeutics Market, by Therapy
-
Mexico
- Mexico Pet Cancer Therapeutics Market, by Therapy
- Chemotherapy
- Immunotherapy
- Targeted Therapy
- Combination Therapy
- Mexico Pet Cancer Therapeutics Market, by Route of Administration
- Oral
- Injection
- Mexico Pet Cancer Therapeutics Market, by Species
- Dogs
- Cats
- Mexico Pet Cancer Therapeutics Market, by Application
- Lymphoma
- Mast Cell Cancer
- Melanoma
- Mammary and Squamous Cell Cancer
- Other Applications
- Mexico Pet Cancer Therapeutics Market, by Therapy
-
North America Pet Cancer Therapeutics Market, by Therapy
- Europe
-
Europe Pet Cancer Therapeutics Market, by Therapy
- Chemotherapy
- Immunotherapy
- Targeted Therapy
- Combination Therapy
-
Europe Pet Cancer Therapeutics Market, by Route of Administration
- Oral
- Injection
-
Europe Pet Cancer Therapeutics Market, by Species
- Dogs
- Cats
-
Europe Pet Cancer Therapeutics Market, by Application
- Lymphoma
- Mast Cell Cancer
- Melanoma
- Mammary and Squamous Cell Cancer
- Other Applications
- U. K.
- U.K. Pet Cancer Therapeutics Market, by Therapy
- Chemotherapy
- Immunotherapy
- Targeted Therapy
- Combination Therapy
- U.K. Pet Cancer Therapeutics Market, by Route of Administration
- Oral
- Injection
- U.K. Pet Cancer Therapeutics Market, by Species
- Dogs
- Cats
- U.K. Pet Cancer Therapeutics Market, by Application
- Lymphoma
- Mast Cell Cancer
- Melanoma
- Mammary and Squamous Cell Cancer
- Other Applications
- U.K. Pet Cancer Therapeutics Market, by Therapy
- France
- France Pet Cancer Therapeutics Market, by Therapy
- Chemotherapy
- Immunotherapy
- Targeted Therapy
- Combination Therapy
- France Pet Cancer Therapeutics Market, by Route of Administration
- Oral
- Injection
- France Pet Cancer Therapeutics Market, by Species
- Dogs
- Cats
- France Pet Cancer Therapeutics Market, by Application
- Lymphoma
- Mast Cell Cancer
- Melanoma
- Mammary and Squamous Cell Cancer
- Other Applications
- France Pet Cancer Therapeutics Market, by Therapy
-
Germany
- Germany Pet Cancer Therapeutics Market, by Therapy
- Chemotherapy
- Immunotherapy
- Targeted Therapy
- Combination Therapy
- Germany Pet Cancer Therapeutics Market, by Route of Administration
- Oral
- Injection
- Germany Pet Cancer Therapeutics Market, by Species
- Dogs
- Cats
- Germany Pet Cancer Therapeutics Market, by Application
- Lymphoma
- Mast Cell Cancer
- Melanoma
- Mammary and Squamous Cell Cancer
- Other Applications
- Germany Pet Cancer Therapeutics Market, by Therapy
-
Italy
- Italy Pet Cancer Therapeutics Market, by Therapy
- Chemotherapy
- Immunotherapy
- Targeted Therapy
- Combination Therapy
- Italy Pet Cancer Therapeutics Market, by Route of Administration
- Oral
- Injection
- Italy Pet Cancer Therapeutics Market, by Species
- Dogs
- Cats
- Italy Pet Cancer Therapeutics Market, by Application
- Lymphoma
- Mast Cell Cancer
- Melanoma
- Mammary and Squamous Cell Cancer
- Other Applications
- Italy Pet Cancer Therapeutics Market, by Therapy
-
Spain
- Spain Pet Cancer Therapeutics Market, by Therapy
- Chemotherapy
- Immunotherapy
- Targeted Therapy
- Combination Therapy
- Spain Pet Cancer Therapeutics Market, by Route of Administration
- Oral
- Injection
- Spain Pet Cancer Therapeutics Market, by Species
- Dogs
- Cats
- Spain Pet Cancer Therapeutics Market, by Application
- Lymphoma
- Mast Cell Cancer
- Melanoma
- Mammary and Squamous Cell Cancer
- Other Applications
- Spain Pet Cancer Therapeutics Market, by Therapy
-
Rest of Europe
- Rest of Europe Pet Cancer Therapeutics Market, by Therapy
- Chemotherapy
- Immunotherapy
- Targeted Therapy
- Combination Therapy
- Rest of Europe Pet Cancer Therapeutics Market, by Route of Administration
- Oral
- Injection
- Rest of Europe Pet Cancer Therapeutics Market, by Species
- Dogs
- Cats
- Rest of Europe Pet Cancer Therapeutics Market, by Application
- Lymphoma
- Mast Cell Cancer
- Melanoma
- Mammary and Squamous Cell Cancer
- Other Applications
- Rest of Europe Pet Cancer Therapeutics Market, by Therapy
-
Europe Pet Cancer Therapeutics Market, by Therapy
- Asia Pacific
-
Asia Pacific Pet Cancer Therapeutics Market, by Therapy
- Chemotherapy
- Immunotherapy
- Targeted Therapy
- Combination Therapy
-
Asia Pacific Pet Cancer Therapeutics Market, by Route of Administration
- Oral
- Injection
-
Asia Pacific Pet Cancer Therapeutics Market, by Species
- Dogs
- Cats
-
Asia Pacific Pet Cancer Therapeutics Market, by Application
- Lymphoma
- Mast Cell Cancer
- Melanoma
- Mammary and Squamous Cell Cancer
- Other Applications
- China
- China Pet Cancer Therapeutics Market, by Therapy
- Chemotherapy
- Immunotherapy
- Targeted Therapy
- Combination Therapy
- China Pet Cancer Therapeutics Market, by Route of Administration
- Oral
- Injection
- China Pet Cancer Therapeutics Market, by Species
- Dogs
- Cats
- China Pet Cancer Therapeutics Market, by Application
- Lymphoma
- Mast Cell Cancer
- Melanoma
- Mammary and Squamous Cell Cancer
- Other Applications
- China Pet Cancer Therapeutics Market, by Therapy
- Japan
- Japan Pet Cancer Therapeutics Market, by Therapy
- Chemotherapy
- Immunotherapy
- Targeted Therapy
- Combination Therapy
- Japan Pet Cancer Therapeutics Market, by Route of Administration
- Oral
- Injection
- Japan Pet Cancer Therapeutics Market, by Species
- Dogs
- Cats
- Japan Pet Cancer Therapeutics Market, by Application
- Lymphoma
- Mast Cell Cancer
- Melanoma
- Mammary and Squamous Cell Cancer
- Other Applications
- Japan Pet Cancer Therapeutics Market, by Therapy
-
Germany
- Germany Pet Cancer Therapeutics Market, by Therapy
- Chemotherapy
- Immunotherapy
- Targeted Therapy
- Combination Therapy
- Germany Pet Cancer Therapeutics Market, by Route of Administration
- Oral
- Injection
- Germany Pet Cancer Therapeutics Market, by Species
- Dogs
- Cats
- Germany Pet Cancer Therapeutics Market, by Application
- Lymphoma
- Mast Cell Cancer
- Melanoma
- Mammary and Squamous Cell Cancer
- Other Applications
- Germany Pet Cancer Therapeutics Market, by Therapy
-
India
- India Pet Cancer Therapeutics Market, by Therapy
- Chemotherapy
- Immunotherapy
- Targeted Therapy
- Combination Therapy
- India Pet Cancer Therapeutics Market, by Route of Administration
- Oral
- Injection
- India Pet Cancer Therapeutics Market, by Species
- Dogs
- Cats
- India Pet Cancer Therapeutics Market, by Application
- Lymphoma
- Mast Cell Cancer
- Melanoma
- Mammary and Squamous Cell Cancer
- Other Applications
- India Pet Cancer Therapeutics Market, by Therapy
-
South Korea
- South Korea Pet Cancer Therapeutics Market, by Therapy
- Chemotherapy
- Immunotherapy
- Targeted Therapy
- Combination Therapy
- South Korea Pet Cancer Therapeutics Market, by Route of Administration
- Oral
- Injection
- South Korea Pet Cancer Therapeutics Market, by Species
- Dogs
- Cats
- South Korea Pet Cancer Therapeutics Market, by Application
- Lymphoma
- Mast Cell Cancer
- Melanoma
- Mammary and Squamous Cell Cancer
- Other Applications
- South Korea Pet Cancer Therapeutics Market, by Therapy
-
South East Asia
- South East Asia Pet Cancer Therapeutics Market, by Therapy
- Chemotherapy
- Immunotherapy
- Targeted Therapy
- Combination Therapy
- South East Asia Pet Cancer Therapeutics Market, by Route of Administration
- Oral
- Injection
- South East Asia Pet Cancer Therapeutics Market, by Species
- Dogs
- Cats
- South East Asia Pet Cancer Therapeutics Market, by Application
- Lymphoma
- Mast Cell Cancer
- Melanoma
- Mammary and Squamous Cell Cancer
- Other Applications
- South East Asia Pet Cancer Therapeutics Market, by Therapy
-
Rest of Asia Pacific
- Rest of Asia Pacific Pet Cancer Therapeutics Market, by Therapy
- Chemotherapy
- Immunotherapy
- Targeted Therapy
- Combination Therapy
- Rest of Asia Pacific Pet Cancer Therapeutics Market, by Route of Administration
- Oral
- Injection
- Rest of Asia Pacific Pet Cancer Therapeutics Market, by Species
- Dogs
- Cats
- Rest of Asia Pacific Pet Cancer Therapeutics Market, by Application
- Lymphoma
- Mast Cell Cancer
- Melanoma
- Mammary and Squamous Cell Cancer
- Other Applications
- Rest of Asia Pacific Pet Cancer Therapeutics Market, by Therapy
-
Asia Pacific Pet Cancer Therapeutics Market, by Therapy
- Latin America
-
Latin America Pet Cancer Therapeutics Market, by Therapy
- Chemotherapy
- Immunotherapy
- Targeted Therapy
- Combination Therapy
-
Latin America Pet Cancer Therapeutics Market, by Route of Administration
- Oral
- Injection
-
Latin America Pet Cancer Therapeutics Market, by Species
- Dogs
- Cats
-
Latin America Pet Cancer Therapeutics Market, by Application
- Lymphoma
- Mast Cell Cancer
- Melanoma
- Mammary and Squamous Cell Cancer
- Other Applications
- Brazil
- Brazil Pet Cancer Therapeutics Market, by Therapy
- Chemotherapy
- Immunotherapy
- Targeted Therapy
- Combination Therapy
- Brazil Pet Cancer Therapeutics Market, by Route of Administration
- Oral
- Injection
- Brazil Pet Cancer Therapeutics Market, by Species
- Dogs
- Cats
- Brazil Pet Cancer Therapeutics Market, by Application
- Lymphoma
- Mast Cell Cancer
- Melanoma
- Mammary and Squamous Cell Cancer
- Other Applications
- Brazil Pet Cancer Therapeutics Market, by Therapy
- Argentina
- Argentina Pet Cancer Therapeutics Market, by Therapy
- Chemotherapy
- Immunotherapy
- Targeted Therapy
- Combination Therapy
- Argentina Pet Cancer Therapeutics Market, by Route of Administration
- Oral
- Injection
- Argentina Pet Cancer Therapeutics Market, by Species
- Dogs
- Cats
- Argentina Pet Cancer Therapeutics Market, by Application
- Lymphoma
- Mast Cell Cancer
- Melanoma
- Mammary and Squamous Cell Cancer
- Other Applications
- Argentina Pet Cancer Therapeutics Market, by Therapy
-
Rest of Latin America
- Rest of Latin America Pet Cancer Therapeutics Market, by Therapy
- Chemotherapy
- Immunotherapy
- Targeted Therapy
- Combination Therapy
- Rest of Latin America Pet Cancer Therapeutics Market, by Route of Administration
- Oral
- Injection
- Rest of Latin America Pet Cancer Therapeutics Market, by Species
- Dogs
- Cats
- Rest of Latin America Pet Cancer Therapeutics Market, by Application
- Lymphoma
- Mast Cell Cancer
- Melanoma
- Mammary and Squamous Cell Cancer
- Other Applications
- Rest of Latin America Pet Cancer Therapeutics Market, by Therapy
-
Latin America Pet Cancer Therapeutics Market, by Therapy
- Middle East & Africa
-
Middle East & Africa Pet Cancer Therapeutics Market, by Therapy
- Chemotherapy
- Immunotherapy
- Targeted Therapy
- Combination Therapy
-
Middle East & Africa Pet Cancer Therapeutics Market, by Route of Administration
- Oral
- Injection
-
Middle East & Africa Pet Cancer Therapeutics Market, by Species
- Dogs
- Cats
-
Middle East & Africa Pet Cancer Therapeutics Market, by Application
- Lymphoma
- Mast Cell Cancer
- Melanoma
- Mammary and Squamous Cell Cancer
- Other Applications
- GCC Countries
- GCC Countries Pet Cancer Therapeutics Market, by Therapy
- Chemotherapy
- Immunotherapy
- Targeted Therapy
- Combination Therapy
- GCC Countries Pet Cancer Therapeutics Market, by Route of Administration
- Oral
- Injection
- GCC Countries Pet Cancer Therapeutics Market, by Species
- Dogs
- Cats
- GCC Countries Pet Cancer Therapeutics Market, by Application
- Lymphoma
- Mast Cell Cancer
- Melanoma
- Mammary and Squamous Cell Cancer
- Other Applications
- GCC Countries Pet Cancer Therapeutics Market, by Therapy
- South Africa
- South Africa Pet Cancer Therapeutics Market, by Therapy
- Chemotherapy
- Immunotherapy
- Targeted Therapy
- Combination Therapy
- South Africa Pet Cancer Therapeutics Market, by Route of Administration
- Oral
- Injection
- South Africa Pet Cancer Therapeutics Market, by Species
- Dogs
- Cats
- South Africa Pet Cancer Therapeutics Market, by Application
- Lymphoma
- Mast Cell Cancer
- Melanoma
- Mammary and Squamous Cell Cancer
- Other Applications
- South Africa Pet Cancer Therapeutics Market, by Therapy
-
Rest of Middle East & Africa
- Rest of Middle East & Africa Pet Cancer Therapeutics Market, by Therapy
- Chemotherapy
- Immunotherapy
- Targeted Therapy
- Combination Therapy
- Rest of Middle East & Africa Pet Cancer Therapeutics Market, by Route of Administration
- Oral
- Injection
- Rest of Middle East & Africa Pet Cancer Therapeutics Market, by Species
- Dogs
- Cats
- Rest of Middle East & Africa Pet Cancer Therapeutics Market, by Application
- Lymphoma
- Mast Cell Cancer
- Melanoma
- Mammary and Squamous Cell Cancer
- Other Applications
- Rest of Middle East & Africa Pet Cancer Therapeutics Market, by Therapy
-
Middle East & Africa Pet Cancer Therapeutics Market, by Therapy
- North America
FAQ
Frequently Asked Question
What is the global demand for Pet Cancer Therapeutics in terms of revenue?
-
The global Pet Cancer Therapeutics valued at USD 411 Million in 2023 and is expected to reach USD 971 Million in 2032 growing at a CAGR of 10.1%.
Which are the prominent players in the market?
-
The prominent players in the market are Boehringer Ingelheim International GmbH (Germany), Zoetis Inc. (U.S.), Dechra Pharmaceuticals PLC (UK), Anivive Lifesciences (U.S.), ELIAS Animal Health (U.S.), QBiotics Group (Australia), Novavive Inc. (Canada), Elanco Animal Health (U.S.), Virbac Corp. (France), Torigen Pharmaceuticals Inc. (U.S.), Elekta (Sweden).
At what CAGR is the market projected to grow within the forecast period?
-
The market is project to grow at a CAGR of 10.1% between 2024 and 2032.
What are the driving factors fueling the growth of the market.
-
The driving factors of the Pet Cancer Therapeutics include
Which region accounted for the largest share in the market?
-
North America was the leading regional segment of the Pet Cancer Therapeutics in 2023.
